CMPX

Compass Therapeutics
CMPX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$286.24M
EV
$166.16M
Shares Outstanding
138.28M
Beta
1.19

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$13.10
P/E 2025E
-
P/Revenue 2025E
180.44x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Compass Therapeutics, Inc.

gainify
CMPX

Compass Therapeutics, Inc.

CMPX

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company’s lead product candidates include CTX-009, a bispecific antibod...

Sector

Healthcare

Industry

Biotechnology

CEO

Schuetz, Thomas

Employees

35

IPO Date

2021-04-05

Headquarters

80 Guest Street, Suite 601, Boston, Massachusetts, 02135, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved